Intracellular pathogens: host immunity and microbial persistence strategies

A Thakur, H Mikkelsen… - Journal of immunology …, 2019 - Wiley Online Library
Infectious diseases caused by pathogens including viruses, bacteria, fungi, and parasites
are ranked as the second leading cause of death worldwide by the World Health …

IgM in microbial infections: taken for granted?

R Racine, GM Winslow - Immunology letters, 2009 - Elsevier
Much has been learned about the structure, function, and production of IgM, since the
antibody's initial characterization. It is widely accepted that IgM provides a first line of …

Salmonella require the fatty acid regulator PPARδ for the establishment of a metabolic environment essential for long-term persistence

NA Eisele, T Ruby, A Jacobson, PS Manzanillo… - Cell host & …, 2013 - cell.com
Host-adapted Salmonella strains are responsible for a number of disease manifestations in
mammals, including an asymptomatic chronic infection in which bacteria survive within …

Type I IFN signaling constrains IL-17A/F secretion by γδ T cells during bacterial infections

T Henry, GS Kirimanjeswara, T Ruby… - The Journal of …, 2010 - journals.aai.org
Recognition of intracellular bacteria by macrophages leads to secretion of type I IFNs.
However, the role of type I IFN during bacterial infection is still poorly understood …

Proteomic characterization and functional analysis of outer membrane vesicles of Francisella novicida suggests possible role in virulence and use as a vaccine

T Pierson, D Matrakas, YU Taylor… - Journal of proteome …, 2011 - ACS Publications
We have isolated and characterized outer membrane vesicles (OMVs) from Francisella.
Transport of effector molecules through secretion systems is a major mechanism by which …

CD4+ T Cells and Antibody Are Required for Optimal Major Outer Membrane Protein Vaccine-Induced Immunity to Chlamydia muridarum Genital Infection

CM Farris, SG Morrison, RP Morrison - Infection and immunity, 2010 - Am Soc Microbiol
Despite effective antimicrobial chemotherapy, control of Chlamydia trachomatis urogenital
infection will likely require a vaccine. We have assessed the protective effect of an outer …

New therapeutic approaches for treatment of tularaemia: a review

S Boisset, Y Caspar, V Sutera… - Frontiers in cellular and …, 2014 - frontiersin.org
Antibiotic treatment of tularaemia is based on a few drugs, including the fluoroquinolones
(eg, ciprofloxacin), the tetracyclines (eg, doxycycline), and the aminoglycosides …

Uncovering the components of the Francisella tularensis virulence stealth strategy

BD Jones, M Faron, JA Rasmussen… - Frontiers in cellular and …, 2014 - frontiersin.org
Over the last decade, studies on the virulence of the highly pathogenic intracellular bacterial
pathogen Francisella tularensis have increased dramatically. The organism produces an …

Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development

LM Roberts, DA Powell, JA Frelinger - Frontiers in cellular and …, 2018 - frontiersin.org
Francisella tularensis is an intracellular bacterium that causes the disease tularemia. There
are several subspecies of F. tularensis whose ability to cause disease varies in humans. The …

Tularemia vaccine development: paralysis or progress?

R Sunagar, S Kumar, BJ Franz… - … development and therapy, 2016 - Taylor & Francis
Francisella tularensis (Ft) is a gram-negative intercellular pathogen and category A biothreat
agent. However, despite 15 years of strong government investment and intense research …